Early AccessImproving daily
Warren Buffett

Buffett Warns: Your 45% ASBISc Position Is a Marriage, Not an Investment

Warren Buffett is roasting your portfolio

Roasted on April 10, 2026

Konta maklerskie (mbank i XTB)
8 assets

Asset Class

Technology41.6%
Healthcare17.7%
Finance14.4%
Other26.3%

Region

Emerging Markets90.8%
Cash Reserves9.2%

Strategy

Income (Yield)41.2%
Growth (Explosive)33.4%
Safety (Hedge)12.9%
Other12.5%

Top Holdings by Weight

1
ASBISc Enterprises Plc
ASB
41.2%
2
Synektik Spólka Akcyjna
SNT
17.7%
3
XTB S.A.
XTB
14.4%
4
Betaetf Wigtech Portfelowy Fundusz Inwestycyjny Zamkniety
ETFBCASH
12.9%
5
GreenX Metals Limited
GRX
2.5%
6
4MASS
4MS
0.9%
7
Vivid Games S.A.
VVD
0.8%
8
Zortrax
ZRX
0.4%
💵
Cash Reserves
9.2%
Intro

Welcome to Omaha, Let's Talk About Your 15% Dream

Grab a chair and pop open a Cherry Coke with me. I was just looking over your portfolio data, and I have to admit, it gave me a good chuckle. You’ve marked yourself down as a "Value Investor" with a 20-year horizon—which I love, because time is the friend of the wonderful business. But then I saw your expected annual return: 15%. My old partner Charlie Munger used to say, "The best way to guarantee a life of misery is to expect 15% annual returns." Even at Berkshire, we don't underwrite with that kind of unchecked optimism!


You’ve built yourself a fiercely independent portfolio on the Warsaw Stock Exchange. I always tell folks to invest in what they know, and clearly, you know your local market. But there is a fine line between conviction and stubbornness, and looking at how you've stacked your chips, I think Mr. Market might be getting ready to teach you a lesson in humility. Let's look under the hood.

Analysis

Examining Your Warsaw Juggernaut

First off, I see you are holding a cash reserve of about 9.2%. I commend you for that. Cash is dead capital when it just sits there, but it’s the only asset that gives you the flexibility to act when Mr. Market inevitably gets depressed and starts offering bargains. Keep that dry powder ready.


Looking at your sector breakdown, you are heavily tilted toward Technology, which makes up almost 46% of your holdings, followed by Healthcare at about 19.5% and Finance at 15.8%. You've categorized a good chunk of your portfolio as having "Scale Advantage" moats, which warms my heart. A business without a moat is like a castle without walls—eventually, the invaders take the gold.


But here’s the kicker: your true overall exposure is almost entirely riding on just one horse. ASBISc Enterprises makes up a staggering 45.3% of your entire portfolio. You've classified it as an income-generating tech play, and while I appreciate a business that throws off cash, having nearly half your net worth tied up in a single IT distributor is a breathtaking level of concentration. You've balanced it slightly with Synektik and XTB, but your geographic exposure is 99.8% in Emerging Markets. You're betting the entire farm on the Polish economy and the broader Eastern European region.

Red Flags

Where The Crocodiles Might Breach Your Moat

Let's not beat around the bush. Here is where I think you are cruising for a bruising:


🚩 The 45% Elephant: Putting 45.3% of your money into ASBISc isn't value investing; it's practically a marriage. Unless you personally audit their warehouses and know their supply chain better than the CEO, this is an unacceptable level of single-stock risk. If their margins compress, your portfolio gets cut in half.


🚩 100% Home Country Bias: Your geographic exposure lacks any developed market anchors. Betting 99.8% on one emerging market region ignores the economic tailwinds of the rest of the world. What happens if regional geopolitics or local currency issues disrupt the Warsaw exchange?


🚩 Delusional Return Expectations: Expecting 15% annually for 20 years is asking for psychological pain. When you aim for 15%, you end up taking hidden risks or reaching for yield, which usually results in permanent loss of capital.


🚩 Financial Weeds: You have less than 1% allocated to speculative plays like Vivid Games, Zortrax, and 4MASS. Charlie used to call this "deworsification." If a business isn't wonderful enough to put 10% of your money into, it isn't worth 1% either. Weeds pull down the flowers.

Verdict

The Oracle's Prescription

I'll give this portfolio a 4.5 out of 10. You have a great time horizon, a healthy cash buffer, and you are trying to buy businesses with scale advantages. But your massive concentration risk and lack of geographic diversification leave you incredibly vulnerable.


Here is what I would do if I were managing your money:


1. Trim the Elephant: Gradually reduce your ASBISc position. Take some of those profits and redeploy them into a broader, more stable base. No single stock should be 45% of your portfolio unless your last name is the same as the company's.

2. Buy the World: You need developed market exposure. Look into low-cost S&P 500 or global index funds. Never bet against the American economic machine.

3. Pull the Weeds: Sell the tiny speculative positions under 2%. They are just a distraction. Focus your capital and your reading time on your highest-conviction businesses.

4. Lower Your Expectations: Adjust your expected return to a realistic 8-10%. If you get 15%, consider it a happy accident, but don't plan your retirement on it.


Always remember: “A wonderful company at a fair price beats a fair company at a wonderful price.” Stick to the wonderful businesses, diversify your geography, and let compounding do the heavy lifting.

About This Analysis

This portfolio roast was generated by PortfolioGlance’s AI, analyzing your portfolio from the perspective of Warren Buffett. The analysis evaluates asset allocation, sector concentration, geographic diversification, risk factors, and provides actionable recommendations.

This is an AI-generated educational analysis, not financial advice. Always consult a qualified financial advisor before making investment decisions.